EURACTIV PR

An easy way of publishing your relevant EU press releases.

Medicines for Europe

Press Releases of this organisation

TITLEsort descending ORGANISATION DATE TOPIC
2017 Biosimilar Medicines Policy Overview: better access is crucial; tailored solutions essential for EU governments Medicines for Europe 12 Sep 2017 Health & Consumers
2018 – A year of unprecedented challenges and opportunities for pharmaceutical regulatory systems Medicines for Europe 25 Jan 2018 Health & Consumers
62% of Medicines Dispensed in Europe are Generic, according to IMS New Data Medicines for Europe 15 Jun 2017 Health & Consumers
A DIGITAL FUTURE FOR VALUE ADDED MEDICINES – IQVIA publication shares the future of the sector Medicines for Europe 24 Sep 2019 Health & Consumers
Access, sustainability and manufacturing competitiveness highlighted at global generic, biosimilar and value added pharmaceutical conference in Budapest Medicines for Europe 14 Jun 2018 Health & Consumers
Addressing medicine shortages in Europe: Competition is crucial for patient access Medicines for Europe 29 Sep 2017 Health & Consumers, Competition
Biosimilar Medicines Opportunity: Dramatic Increase in Patient Access across Europe Medicines for Europe 09 May 2017 Health & Consumers
Biosimilar medicines: competition, sustainability and early* access on the agenda of DG GROW stakeholder workshop Medicines for Europe 30 Oct 2019 Health & Consumers
Biosimilar Medicines: essential for sustainable access to medicines Medicines for Europe 27 Apr 2018 Health & Consumers
Brexit - Life Science Industry Joint Position Paper Medicines for Europe 14 Dec 2017 Health & Consumers, UK in Europe
CJEU decision on Gilead’s SPC on Truvada® leads to successful clarification in English court Medicines for Europe 20 Sep 2018 Health & Consumers
Commission sponsored study shows Supplementary Protection Certificate (SPC) Manufacturing Waiver will create Jobs, strengthen the pharmaceutical sector and reduce medicine costs Medicines for Europe 18 Oct 2017 Health & Consumers
Competition policy essential for access to medicines Medicines for Europe 29 Jan 2019 Health & Consumers
Comprehensive SPC manufacturing waiver key for patient access to medicines, jobs and growth in Europe Medicines for Europe 28 May 2018 Health & Consumers, Social Europe & Jobs
Crucial European Parliament vote vastly improves SPC manufacturing waiver Medicines for Europe 24 Jan 2019 Health & Consumers
Driving local excellence, delivering European results Medicines for Europe 06 Nov 2018 Health & Consumers
Efficient use of pharmacovigilance data essential for patient safety Medicines for Europe 30 Jan 2019 Health & Consumers
EU manufacturers call for urgent reforms to achieve reciprocity and a level-playing field in public procurement Medicines for Europe 30 Sep 2019 Health & Consumers
EU Semester Country Specific Recommendations: Improve patient access to medicine and ensure healthcare sustainability Medicines for Europe 24 May 2018 Health & Consumers
EU Semester Country Specific Recommendations: More Efficient Medicine Policies Needed for Patient Access Medicines for Europe 23 May 2017 Health & Consumers
European Commission launches: “What I need to know about Biosimilar Medicines - Information for patients”, in 23 EU languages Medicines for Europe 29 Nov 2017 Health & Consumers
European Organisation for Specialised Nurses (ESNO) launches switch management guide between similar biological medicines - a guide for nurses Medicines for Europe 26 Jun 2018 Health & Consumers
Europe’s life science industry urges the UK and EU27 to safeguard patients’ access to medicines with a clear transition period and a future cooperation agreement after Brexit Medicines for Europe 28 Nov 2017 Health & Consumers, UK in Europe
Fulfilling the Biosimilar Promise: Report Highlights Key Principles in Support of a Sustainable Market Medicines for Europe 19 Sep 2016 Health & Consumers
Generic & biosimilar medicines pivotal for safe, effective and affordable access to medicines in Europe Medicines for Europe 28 Nov 2019 Health & Consumers
Health at a Glance Report highlights public value of generic, biosimilar and value added medicines Medicines for Europe 26 Nov 2018 Health & Consumers
IGBA congratulates the Australian Government for maintaining their Biologics Naming Convention and for strengthening pharmacovigilance Medicines for Europe 29 Jan 2018 Health & Consumers
IGBA launches a Biosimilar Medicines Information Campaign Medicines for Europe 01 Feb 2018 Health & Consumers
Immediately calls on new President of EU Commission to prioritise Healthcare Medicines for Europe 25 Sep 2019 Health & Consumers, InfoSociety
Latest Data Shows the Need to Promote Biosimilar and Value Added Medicines for Better Health Medicines for Europe 16 Jun 2017 Health & Consumers

Pages